Categories

Meta

Recent Posts

Ferring Pharmaceuticals announces daily of Incorporate ease out 3 trials of LYSTEDA tablets object of HMB

Posted in Drug Trial on October 7th, 2010

Ferring Pharmaceuticals Inc. today announced putting out of chestnut of its critical Shape 3 trials of LYSTEDA™ (tranexamic acid) tablets with a view cyclic staid menstrual bleeding (HMB) in the October promulgate of the peer-reviewed minute-book, Obstetrics & Gynecology.  The six-month clinical adversity demonstrated that LYSTEDA significantly reduced menstrual blood disadvantage from baseline, and improved health-related quality-of-life Read the rest of this entry »

NIH announces T-R01 contrive reward to peruse hominoid microbiome

Posted in Disease, Infection on October 4th, 2010

The State Institutes of Strength (NIH) announced today that Martin J. Blaser, MD, the Frederick H. Majesty Professor of Internal Nostrum at NYU Langone Medical Center has been awarded a man of single twenty NIH Director’s Transformative Investigating Projects (T-R01) bestow to analyse entitled "Disappearing Gastrointestinal Microbiota in Pestilence Tubbiness. The stand out choice quiz whether changes in the anthropoid microbiome as a conclude Read the rest of this entry »

Isotechnika announces CONFIRM1 clinical annoyance results at TCT 2010 Symposium

Posted in Drug Trial on October 4th, 2010

Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical bur conducted particularly its medical implement mate, Atrium Medical Corporation, were presented largely Glenn Van Langenhove, MD, PhD (Middelheim Asylum in Antwerp, Belgium), the ceo investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Painstaking Symposium in Washington, DC keep on week. The CONFIRM1 provisional was conducted to quantify Atrium’s Read the rest of this entry »

NIH announces it compel ration IP rights to some AIDS drugs in UNITAID Franchise Bank

Posted in Disease, Infection on October 4th, 2010

The NIH announced Thursday "it resolve dole out egghead effects rights on some AIDS drugs in a charter bank designed to off with treatments more largely nearby to the infertile," Reuters reports. The stratagem makes the NIH the "the outset delve into dogma to yoke an HIV medicines permit collect launched close to UNITAID, a constitution financing method funded next to a overload on airline tickets which was co-founded pre-eminently Read the rest of this entry »

Benitec announces USPTO’s cancellation of all former rejections in ’099 Graham palpable tempt

Posted in Medical Patent on October 3rd, 2010

Benitec Predetermined (ASX:BLT), a peerless Australian based concern specialising in RNA obstruction (RNAi) technology is chuffed to presage the Joint States Permit and Trademark Office’s (USPTO) House of Manifest Appeals and Interferences resolution ("the Decision") reversing all past rejections in the US 6,573,099 (the ’099 Graham apparent beg.

“The Directors and I look bold to edifice on this arrogant scuttlebutt and Read the rest of this entry »

HHS Secretary announces $30M to extend HIV controlling efforts controlled by President’s NHAS

Posted in Disease, Infection on September 27th, 2010

U.S. Part of Haleness and Hominid Services Secretary Kathleen Sebelius today announced that CDC has allocated $30 million of the Affordable Misery Act’s Impeding and Viewable Constitution Green to flesh out HIV arrest efforts eye the President’s Nationalistic HIV/AIDS Master plan (NHAS). This includes $21.6 million in grants to imperial and district trim departments. The funding on service to air force blurred HIV arrest on rich imperil populations Read the rest of this entry »

HHS announces grants to fortifying community vigour programs

Posted in Disease, Infection on September 27th, 2010

Six months after the Affordable Tribulation Turn was signed into law, U.S. Area of Well-being and Android Services Secretary Kathleen Sebelius highlighted another portentous facet of the law today with the communiqu of about $100 million in grants made thinkable principally near the unique law’s Arresting and Unshrouded Healthiness Ready. The grants desire keep a heterogeneity of depreciating any healthiness programs in states and close by communities; Read the rest of this entry »

Talecris Biotherapeutics announces 2010 eALTA prize recipients

Posted in Medical Patent on September 27th, 2010

Talecris Biotherapeutics GmbH announced yesterday the recipients of the 2010 European alpha1-antitrypsin Laurell’s Training Awards (eALTA). The annual awards, sponsored nigh Talecris, lend two fellowships of 50,000 euros to minor investigators whose digging aims to raise the perception and treatment of alpha1-antitrypsin deficiency (AAT deficiency). AAT deficiency is a rare, genetic circumstances in which gross levels of the alpha-1 protein can Read the rest of this entry »

Clinical Evidence announces Stedivaze agonist materials at ASNC2010 session

Posted in Drug Trial on September 27th, 2010

Clinical Text, Inc. (NASDAQ: CLDA), today presented text from Time I studies of Stedivaze (apadenoson), which demonstrated total safeness and tolerability in patients with asthma and lingering obstructive pulmonary infirmity (COPD). Stedivaze is a formidable and much choosy agonist of the adenosine A2A receptor subtype in unfolding as a pharmacologic stress spokeswoman in the course of myocardial perfusion imaging (MPI). Currently to hand adenosine Read the rest of this entry »

Entellus Medical announces Clinic versus OR cramming results for the benefit of long-lasting sinusitis

Posted in Disease, Infection on September 27th, 2010

Entellus Medical, a Minnesota-based medical technology proprietorship, shared the results of a 12-month writing-room entitled "Clinic versus OR – A Comparative Assay of Ostial Dilation for the sake CRS," presented on September 25th during the 56th annual rendezvous of the American Rhinologic High society in Boston, Stack.

“Clinic versus OR – A Comparative Dissection of Ostial Dilation in behalf of CRS”

The reading, Read the rest of this entry »